Pandemic-Era Breast Cancer Patients Face Prolonged Delays in Reconstruction Surgeries

“I have to look at this every day… it has completely changed how I live my life.”

Hundreds of breast cancer patients who underwent mastectomies during the Covid-19 pandemic without immediate reconstruction continue to face prolonged delays in accessing follow-up surgery, highlighting ongoing strain on healthcare capacity and the long-term consequences of pandemic-era clinical prioritisation.

At the height of the pandemic in 2020 and 2021, hospitals across the United Kingdom deferred what were classified as non-essential procedures in order to preserve critical care capacity and reduce infection risks. Among the services widely paused was breast reconstruction surgery, particularly procedures involving complex tissue transfer from the abdomen, which require extended operating time and large surgical teams.

Patients requiring urgent cancer treatment were prioritised for mastectomies, often without simultaneous reconstruction that would ordinarily be performed during the same operation. At the time, many were advised that reconstructive procedures would be offered once restrictions eased and hospital services stabilised.

Five years later, some patients report that those assurances have yet to materialise.Julie Ford, 62, underwent a mastectomy and lymph node removal in April 2021. Due to pandemic protocols, she attended the hospital alone and was discharged the same day following surgery. Reconstruction was not performed at the time, in line with broader NHS policy during peak Covid conditions.

Ford said the absence of reconstruction has had a sustained impact on her daily life. “I have to look at this every day,” she said, describing ongoing physical discomfort and changes in body image following surgery.

She added that the delay has affected her confidence and social interactions, limiting her willingness to engage in routine activities.Healthcare providers had indicated that patients like Ford would be eligible for reconstruction once services resumed. However, a combination of factors including a shortage of specialist surgeons, limited operating theatre capacity, and the need to prioritise newly diagnosed cancer patients has contributed to extended waiting times.

The backlog has also affected patients who have since become eligible for reconstruction after meeting clinical requirements. Alison, another patient referenced in the case data, was approved for surgery in early 2025 after reaching a target weight.

However, an administrative error led to her being incorrectly referred under a different clinical category, delaying her placement on the appropriate waiting list.She was subsequently added to a 65-week waiting list in June 2025. The delay required her to restart the referral process, extending an already prolonged timeline between initial cancer treatment and reconstructive care.

A spokesperson for Manchester University NHS Foundation Trust acknowledged the error and said new electronic referral systems had been introduced to reduce the risk of similar incidents.The spokesperson stated that reconstructive surgery remains an important component of post-cancer recovery and is prioritised based on clinical need, while also recognising capacity constraints within the system.

The effects of pandemic-related service disruptions are also being felt by more recent patients. Rebecca Joselyn, 43, underwent a mastectomy in December 2023 and has been advised that reconstruction may not be available before the end of 2027. In the interim, she relies on a prosthetic, which she reports as physically uncomfortable and difficult to manage.

Joselyn described the practical challenges associated with the prosthetic, including the need for specialised clothing and limitations in physical activity. The delay in reconstruction has extended her recovery timeline, reflecting broader systemic pressures on elective surgical services.

The National Health Service has faced sustained backlogs across multiple specialities following the pandemic. According to publicly available NHS data, elective procedures experienced significant disruption during Covid-19, with millions of appointments and operations postponed.

While recovery plans have been implemented, workforce shortages and resource limitations continue to affect service delivery.Breast reconstruction surgery, particularly autologous reconstruction using the patient’s own tissue, is resource-intensive and typically scheduled alongside other elective procedures.

As a result, it remains vulnerable to delays when healthcare systems prioritise urgent and life-saving treatments.Clinical guidelines generally recognise reconstruction as an important aspect of holistic cancer care, contributing to physical recovery and psychological wellbeing.

However, classification as non-urgent during crisis conditions has had lasting implications for patients whose procedures were deferred.In several cases, patients reported waiting years between mastectomy and reconstruction, a gap significantly longer than standard clinical timelines under normal operating conditions.

The extended interval has introduced additional physical and emotional challenges, as patients adapt to long-term changes in their bodies while awaiting further treatment.Healthcare providers have indicated that efforts are ongoing to address surgical backlogs, including expanded operating hours and revised prioritisation frameworks.

However, demand continues to exceed available capacity in certain specialities, including reconstructive surgery.For patients affected during the pandemic, the delays represent a continuation of disruption that began during the initial phase of crisis response.

While emergency measures taken during Covid-19 were aimed at preserving life and managing system-wide risk, their downstream effects are still being addressed across the healthcare sector.As hospitals continue to balance new cancer cases with existing waiting lists, the timeline for resolving these backlogs remains uncertain.

Patients awaiting reconstruction are likely to remain dependent on incremental improvements in capacity, workforce availability, and administrative efficiency within the system.